IVAX Diagnostics, Inc. Signs Distribution Agreement with Augurix SA for the First Approved Rapid Test for Celiac Disease

MIAMI--(BUSINESS WIRE)--IVAX Diagnostics, Inc. (AMEX:IVD), a fully integrated in vitro diagnostics company, has signed a distribution agreement with Augurix SA for Simtomax® Blood Drop, the first one-step rapid test that accurately diagnoses celiac disease in all patients. Celiac disease, also known as gluten intolerance, is a food intolerance to three cereals widely present in food, wheat, barley and rye that afflicts about 1% of the global population. The prevalence and incidence of the disease in the key markets covered by the agreement (i.e., France, Germany, Italy, Spain and the U.K) exceeds 1 million and 31,000 people, respectively.